Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257990 | PMC |
| http://dx.doi.org/10.1002/cac2.12296 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of Key Genes and Signaling Pathways in Entrectinibresistant Non-small Cell Lung Cancer Using Bioinformatic Analysis and Experimental Verification.
Curr Med Chem
August 2024
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Background: Entrectinib, a ROS1 inhibitor, is effective in patients with ROS1-positive non-small-cell lung cancer (NSCLC). However, entrectinib resistance remains a challenge worldwide. The biomarkers of entrectinib resistance and molecular mechanisms have not been clarified based on the Gene Expression Omnibus (GEO) database.
View Article and Find Full Text PDFA study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis.
Aging (Albany NY)
February 2024
School of Clinical Medicine, Guizhou Medical University, Guiyang, China.
Article Synopsis
- Pancreatic adenocarcinoma (PAAD) is a serious pancreatic cancer with limited treatment options due to unclear causes and early detection challenges.
- Researchers used weighted gene co-expression network analysis (WGCNA) to identify 11 key genes linked to PAAD progression and prognosis from the GEPIA database.
- They found that Taxifolin, a natural compound, shows promise in treating PAAD by inducing cancer cell death and inhibiting their spread, possibly through the HIF-1 signaling pathway.
Establishment of a prognostic model toward lung squamous cell carcinoma based on mG-related genes in the cancer genome atlas.
Physiol Genomics
October 2023
School of Public Health, North China University of Science and Technology, Tangshan, People's Republic of China.
Lung squamous cell carcinoma (LUSC) is a non-small cell lung cancer with a poor prognosis owing to late diagnosis. New molecular markers are urgently needed to improve the diagnosis and prognosis of LUSC. 7-Methylguanosine (mG) modifications, a tRNA modification, are common in eubacteria, eukaryotes, and a few archaea.
View Article and Find Full Text PDFPrognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes.
J Gastrointest Oncol
June 2023
Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Background: The incidence and mortality of pancreatic cancer are almost the same, and the 5-year survival rate is less than 10%. The high mortality of pancreatic cancer is related to chemo-radiotherapy. The present study aimed to establish a prognostic signature of pancreatic cancer based on chemo-radiotherapy resistant-related genes (CRRGs).
View Article and Find Full Text PDFEpigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
Oncogene
May 2023
Molecular Oncology, PSL Research University, CNRS, UMR 144, Institut Curie, Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
Muscle-invasive bladder cancer (BLCA) is an aggressive disease. Consensus BLCA transcriptomic subtypes have been proposed, with two major Luminal and Basal subgroups, presenting distinct molecular and clinical characteristics. However, how these distinct subtypes are regulated remains unclear.
View Article and Find Full Text PDF